Literature DB >> 17638589

Restless legs syndrome (RLS) with expansion of symptoms to the face.

Mark J Buchfuhrer1.   

Abstract

BACKGROUND: It has been well established that restless legs syndrome (RLS) manifests with symptoms most frequently in the legs followed by the arms. Other body parts may be affected but it has been somewhat controversial as to whether symptoms may extend to the face.
METHODS: We are reporting two cases of RLS showing unusual extension of symptoms.
RESULTS: These two patients presented with symptoms which extended to body parts beyond the legs, including to the face. The facial symptoms can be relieved by walking, massage or medication.
CONCLUSION: It is important to be aware of unusual extension of symptoms either as progression of the disease or as manifestation of augmentation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17638589     DOI: 10.1016/j.sleep.2007.02.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  4 in total

1.  Depth and Distribution of Symptoms in Restless Legs Syndrome/ Willis-Ekbom Disease.

Authors:  Paul Yeh; William G Ondo; Daniel L Picchietti; J Steven Poceta; Richard P Allen; Charles R Davies; Lily Wang; Yaping Shi; Kanika Bagai; Arthur S Walters
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

2.  Chronic back pain cured by low-dose levodopa: is it a variant of restless legs syndrome?

Authors:  Zhi-Fen Zeng; Yan-Ran Liang; Ying Chen; Xiu-Na Jing; Su-Dan Peng; En-Xiang Tao
Journal:  J Pain Res       Date:  2018-02-02       Impact factor: 3.133

3.  Restless legs syndrome: differential diagnosis and management with rotigotine.

Authors:  Giovanni Merlino; Anna Serafini; Francesca Robiony; Mariarosaria Valente; Gian Luigi Gigli
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

Review 4.  Restless legs syndrome: An overview of pathophysiology, comorbidities and therapeutic approaches (Review).

Authors:  Andrei Vlasie; Simona Corina Trifu; Cristiana Lupuleac; Bianca Kohn; Mihai Bogdan Cristea
Journal:  Exp Ther Med       Date:  2021-12-30       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.